These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27943503)

  • 1. Invasive fungal infection after heart transplantation: A 7-year, single-center experience.
    Echenique IA; Angarone MP; Gordon RA; Rich J; Anderson AS; McGee EC; Abicht TO; Kang J; Stosor V
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
    Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
    Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.
    Crespo-Leiro MG; Alonso-Pulpón L; Arizón JM; Almenar L; Delgado JF; Palomo J; Manito N; Rábago G; Lage E; Diaz B; Roig E; Pascual D; Blasco T; de la Fuente L; Campreciós M; Vázquez de Prada JA; Muñiz J
    J Heart Lung Transplant; 2007 Nov; 26(11):1105-9. PubMed ID: 18022075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study.
    Bucheli E; Kralidis G; Boggian K; Cusini A; Garzoni C; Manuel O; Meylan PR; Mueller NJ; Khanna N; van Delden C; Berger C; Koller MT; Weisser M;
    Transpl Infect Dis; 2014 Feb; 16(1):26-36. PubMed ID: 24330137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
    Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
    Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Pappas PG; Alexander BD; Andes DR; Hadley S; Kauffman CA; Freifeld A; Anaissie EJ; Brumble LM; Herwaldt L; Ito J; Kontoyiannis DP; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Perl TM; Oster RA; Schuster MG; Walker R; Walsh TJ; Wannemuehler KA; Chiller TM
    Clin Infect Dis; 2010 Apr; 50(8):1101-11. PubMed ID: 20218876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
    Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
    Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
    Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
    J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Biyun L; Yahui H; Yuanfang L; Xifeng G; Dao W
    Clin Microbiol Infect; 2024 May; 30(5):601-610. PubMed ID: 38280518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients.
    Aliabadi AZ; Grömmer M; Dunkler D; Eskandary F; Salameh O; Gökler J; Hutschala D; Steinlechner B; Opfermann P; Laufer G; Zuckermann AO
    Transplantation; 2016 Mar; 100(3):685-93. PubMed ID: 26457604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
    Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
    Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
    Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
    Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
    Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for invasive fungal disease in heart transplant recipients.
    Rabin AS; Givertz MM; Couper GS; Shea MM; Peixoto D; Yokoe DS; Baden LR; Marty FM; Koo S
    J Heart Lung Transplant; 2015 Feb; 34(2):227-32. PubMed ID: 25455750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC
    J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.